Site-oriented depigmentation in vitiligo patients using Q-switched Nd:YAG laser (1064/532nm), cryotherapy and chemical peels: A comparative study.
Phase 4
- Conditions
- Skin and Connective Tissue Diseases
- Registration Number
- PACTR201811835577312
- Lead Sponsor
- Sarah Ibrahim
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients older than 12 years
having either vitiligo universalis that left behind residual normally pigmented and cosmetically unacceptable areas over face, neck and/or upper limbs, or vitiligo vulgaris recalcitrant to treatment and interfering with patients’ social acceptance were included.
Exclusion Criteria
?Active cutaneous infection or inflammatory dermatoses.
?Uncooperative patients.
?Unrealistic expectations.
?History of abnormal scarring.
?Patients having cardiac or renal problems.
?Patients with impaired sensation or circulation, or abnormal reactions to cold (Raynaud's phenomenon and cold urticaria).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The used depigmenting modalities proved to be effective in depigmentation of the remaining pigmented areas in vitiligo cases
- Secondary Outcome Measures
Name Time Method TCA peels are tolerable, cheap and available depigmenting agents in face and/ or neck depigmentation. QsNdYAG, cyotherapy and phenol 88 gave comparable results in upper limb depigmentation.